MERIT MEDICAL SYSTEMS INC(MMSI)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #876 of 2,879 stocksTOP 50%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
MMSI Stock Analysis & AI Quality Score
AI stock analysis and institutional research for MERIT MEDICAL SYSTEMS INC (MMSI), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores MMSI at 60.1/100 on a 32-signal composite quality model, placing it at rank #876 of 2,879 stocks — the top half of the AI-ranked universe. Areas of concern include institutional flow (10.8), which score below median versus the broader universe. Shareholder dilution risk is elevated at 34.7/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), MERIT MEDICAL SYSTEMS INC reports quarterly revenue of $381.9M, net income of $41.0M, an operating margin of 11.6%. Top institutional holders of MMSI by reported 13-F value include BlackRock,, VANGUARD PORTFOLIO MANAGEMENT, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. MMSI trades on the Nasdaq exchange and files with the SEC under CIK 856982. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MMSI daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for MERIT MEDICAL SYSTEMS INC directly from SEC EDGAR. MERIT MEDICAL SYSTEMS INC's 13F Pro composite quality score has ranged between 43 and 68 since 2021, currently 60.1 — an improving long-term trajectory across 30 quarterly and live scoring snapshots.
Revenue
Q1 2026
$381.9M
Net Income
Q1 2026
$41.0M
Free Cash Flow
Q1 2026
$24.7M
Operating Margin
Q1 2026
11.6%
ROIC
Q1 2026
1.9%
D/E Ratio
Q1 2026
0.45
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
+11.8% YoYNet Income
+6.8% YoYOperating Income
+18.6% YoYEPS (Diluted)
+4.9% YoYTotal Assets
+11.1% YoYTotal Debt
+0.6% YoYOp. Cash Flow
+34.7% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Revenue | $1.52B +11.8% | $1.36B +7.9% | $1.26B +17.0% | $1.07B +11.5% | $963.9M -3.1% | $994.9M |
| Net Income | $128.5M +6.8% | $120.4M +27.5% | $94.4M +94.8% | $48.5M +592.3% | $-9.8M -280.6% | $5.5M |
| Operating Income | $184.7M +18.6% | $155.7M +25.6% | $123.9M +103.5% | $60.9M +3999.9% | $-1.6M -110.1% | $15.4M |
| EPS (Diluted) | $2.13 +4.9% | $2.03 +25.3% | $1.62 +92.9% | $0.84 +566.7% | $-0.18 -280.0% | $0.10 |
| Total Assets | $2.69B +11.1% | $2.42B +4.0% | $2.33B +41.1% | $1.65B -1.0% | $1.66B -5.3% | $1.76B |
| Total Debt | $734.0M +0.6% | $729.6M -11.4% | $823.0M +227.5% | $251.3M -30.0% | $358.7M -19.7% | $447.0M |
| Operating Cash Flow | $297.4M +34.7% | $220.8M +52.1% | $145.2M -1.4% | $147.2M -10.9% | $165.3M +112.4% | $77.8M |
AI Insight: MMSI Financial Trends
Revenue growth accelerated to 16.5% year-over-year in Q4 2025 while operating cash flow remained volatile, swinging from $99M to $41M quarter-over-quarter.
• Revenue expanded from $338M in Q2 2024 to $382M in Q1 2026, with particularly strong growth in Q2 2025.
• Total debt declined from $801M in Q2 2024 to $735M in Q1 2026, improving leverage profile.
• Equity increased steadily from $1,282M in Q2 2024 to $1,627M in Q1 2026, strengthening balance sheet.
• Net income volatility persisted, ranging from $28M to $41M across recent quarters with no clear trend.
⚠ Operating cash flow dropped sharply from $99M in Q4 2025 to $41M in Q1 2026, continuing erratic pattern.
⚠ Revenue declined 3% sequentially in Q1 2026 after strong Q4 2025 performance, raising sustainability questions.
AI Insight: MMSI Ratio Trends
Merit Medical shows volatile profitability with operating margins swinging from 10.3% to 13.8% over six quarters, while leverage steadily declined from 0.62 to 0.45 debt-to-equity.
• Operating margin fluctuated significantly, ranging from 10.3% in Q4 2024 to 13.8% in Q4 2025.
• Debt-to-equity ratio improved consistently from 0.62 in Q2 2024 to 0.45 in Q1 2026.
• ROE recovered from 7.3% in Q3 2025 to 10.1% in Q1 2026.
⚠ ROIC declined from 9.3% in Q4 2025 to 7.5% in Q1 2026 despite strong ROE performance.
⚠ Operating margin volatility suggests inconsistent operational execution across quarters.
Get alerted when MMSI's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for MERIT MEDICAL SYSTEMS INC including:
Top Institutional Holders of MMSI
BlackRock, Inc.
$608.9M8,834,315 shVANGUARD PORTFOLIO MANAGEMENT LLC
$242.8M3,523,088 shVANGUARD CAPITAL MANAGEMENT LLC
$183.1M2,656,163 shSTATE STREET CORP
$162.7M2,360,982 shConestoga Capital Advisors, LLC
$149.4M2,167,513 shFULLER & THALER ASSET MANAGEMENT, INC.
$145.8M2,115,526 shGEODE CAPITAL MANAGEMENT, LLC
$104.0M1,508,374 shMORGAN STANLEY
$86.9M1,260,959 shDIMENSIONAL FUND ADVISORS LP
$85.3M1,237,298 shNOMURA ASSET MANAGEMENT INTERNATIONAL INC.
$82.6M1,198,269 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $608.9M | 8,834,315 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $242.8M | 3,523,088 |
| VANGUARD CAPITAL MANAGEMENT LLC | $183.1M | 2,656,163 |
| STATE STREET CORP | $162.7M | 2,360,982 |
| Conestoga Capital Advisors, LLC | $149.4M | 2,167,513 |
| FULLER & THALER ASSET MANAGEMENT, INC. | $145.8M | 2,115,526 |
| GEODE CAPITAL MANAGEMENT, LLC | $104.0M | 1,508,374 |
| MORGAN STANLEY | $86.9M | 1,260,959 |
| DIMENSIONAL FUND ADVISORS LP | $85.3M | 1,237,298 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $82.6M | 1,198,269 |
More Healthcare Companies
View all Healthcare →Put MMSI on your watchlist
Track score changes the day MERIT MEDICAL SYSTEMS INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is MMSI a good stock to buy?
13F Pro's AI-powered analysis of MERIT MEDICAL SYSTEMS INC (MMSI) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for MMSI are available on the MMSI stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own MMSI?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling MMSI. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of MERIT MEDICAL SYSTEMS INC's investment landscape.